☰

Victoria Risbrough, Ph.D. - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
psychopharmacology
Tree Info Grants Similar researchers PubMed Report error

79 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Acheson DT, Baker DG, Nievergelt CM, Yurgil KA, Geyer MA, Risbrough VB. Prospective longitudinal assessment of sensorimotor gating as a risk/resiliency factor for posttraumatic stress disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 36192631 DOI: 10.1038/s41386-022-01460-9  0.472
2021 Yue W, Caldwell S, Risbrough V, Powell S, Zhou X. Chronic presence of blood circulating anti-NMDAR1 autoantibodies impairs cognitive function in mice. Plos One. 16: e0256972. PMID 34473764 DOI: 10.1371/journal.pone.0256972  0.584
2021 Stout DM, Powell S, Kangavary A, Acheson DT, Nievergelt CM, Kash T, Simmons AN, Baker DG, Risbrough VB. Dissociable impact of childhood trauma and deployment trauma on affective modulation of startle. Neurobiology of Stress. 15: 100362. PMID 34258336 DOI: 10.1016/j.ynstr.2021.100362  0.606
2021 Stout DM, Powell S, Kangavary A, Acheson DT, Nievergelt CM, Kash T, Simmons AN, Baker DG, Risbrough VB. Dissociable impact of childhood trauma and deployment trauma on affective modulation of startle. Neurobiology of Stress. 15: 100362. PMID 34258336 DOI: 10.1016/j.ynstr.2021.100362  0.606
2020 Friend SF, Nachnani R, Powell SB, Risbrough VB. C-Reactive Protein: Marker of risk for post-traumatic stress disorder and its potential for a mechanistic role in trauma response and recovery. The European Journal of Neuroscience. PMID 33131159 DOI: 10.1111/ejn.15031  0.627
2020 Deslauriers J, Toth M, Scadeng M, McKenna BS, Bussell R, Gresack J, Rissman R, Risbrough VB, Brown GG. DTI-identified microstructural changes in the gray matter of mice overexpressing CRF in the forebrain. Psychiatry Research. Neuroimaging. 304: 111137. PMID 32731113 DOI: 10.1016/J.Pscychresns.2020.111137  0.311
2020 Huckins LM, Chatzinakos C, Breen MS, Hartmann J, Klengel T, da Silva Almeida AC, Dobbyn A, Girdhar K, Hoffman GE, Klengel C, Logue MW, Lori A, Maihofer AX, Morrison FG, Nguyen HT, ... ... Risbrough VB, et al. Analysis of Genetically Regulated Gene Expression Identifies a Prefrontal PTSD Gene, SNRNP35, Specific to Military Cohorts. Cell Reports. 31: 107716. PMID 32492425 DOI: 10.1016/J.Celrep.2020.107716  0.427
2019 Ross JA, Alexis R, Reyes BAS, Risbrough V, Van Bockstaele EJ. Localization of amyloid beta peptides to locus coeruleus and medial prefrontal cortex in corticotropin releasing factor overexpressing male and female mice. Brain Structure & Function. PMID 31250157 DOI: 10.1007/S00429-019-01915-8  0.354
2019 Deslauriers J, Toth M, Zhou X, Risbrough VB. Heritable Differences in Catecholamine Signaling Modulate Susceptibility to Trauma and Response to Methylphenidate Treatment: Relevance for PTSD. Frontiers in Behavioral Neuroscience. 13: 111. PMID 31164811 DOI: 10.3389/Fnbeh.2019.00111  0.332
2019 Mennesson M, Rydgren E, Lipina T, Sokolowska E, Kulesskaya N, Morello F, Ivakine E, Voikar V, Risbrough V, Partanen J, Hovatta I. Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30770891 DOI: 10.1038/S41386-019-0344-5  0.42
2019 Dautzenberg FM, Grigoriadis DE, Hauger RL, Risbrough VB, Steckler T, Vale WW, Valentino RJ. Corticotropin-releasing factor receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f19/2019.4  0.356
2019 Friend S, Caldwell S, Nachnani R, Crossan A, Gao MH, Hammond HK, Risbrough V. S1. Evaluating how CRP Effects Risk for PTSD-Like Behaviors in Trauma-Exposed Mice Biological Psychiatry. 85: S297. DOI: 10.1016/J.Biopsych.2019.03.752  0.379
2018 Stout DM, Acheson DT, Moore TM, Gur RC, Baker DG, Geyer MA, Risbrough VB. Individual variation in working memory is associated with fear extinction performance. Behaviour Research and Therapy. 102: 52-59. PMID 29331727 DOI: 10.1016/J.Brat.2018.01.002  0.395
2017 Wolf EJ, Maniates H, Nugent N, Maihofer AX, Armstrong D, Ratanatharathorn A, Ashley-Koch AE, Garrett M, Kimbrel NA, Lori A, Va Mid-Atlantic Mirecc Workgroup, Aiello AE, Baker DG, Beckham JC, Boks MP, ... ... Risbrough V, et al. Traumatic stress and accelerated DNA methylation age: A meta-analysis. Psychoneuroendocrinology. PMID 29452766 DOI: 10.1016/J.Psyneuen.2017.12.007  0.322
2017 Deslauriers J, Acheson DT, Maihofer AX, Nievergelt CM, Baker DG, Geyer MA, Risbrough VB. COMT val158met polymorphism links to altered fear conditioning and extinction are modulated by PTSD and childhood trauma. Depression and Anxiety. PMID 28833952 DOI: 10.1002/Da.22678  0.453
2017 Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, ... ... Risbrough VB, et al. Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nature Communications. 8: 16140. PMID 28767105 DOI: 10.1038/Ncomms16140  0.307
2017 Deslauriers J, Powell S, Risbrough VB. Immune signaling mechanisms of PTSD risk and symptom development: insights from animal models. Current Opinion in Behavioral Sciences. 14: 123-132. PMID 28758144 DOI: 10.1016/J.Cobeha.2017.01.005  0.627
2017 Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, ... ... Risbrough VB, et al. Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nature Communications. 8: 15805. PMID 28613276 DOI: 10.1038/Ncomms15805  0.326
2017 Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms. Depression and Anxiety. PMID 28489272 DOI: 10.1002/Da.22642  0.439
2017 Deslauriers J, van Wijngaarde M, Geyer MA, Powell S, Risbrough VB. Effects of LPS-induced immune activation prior to trauma exposure on PTSD-like symptoms in mice. Behavioural Brain Research. PMID 28159589 DOI: 10.1016/J.Bbr.2017.01.048  0.689
2017 Deslauriers J, Esders M, Maihofer A, Nievergelt C, Baker D, Geyer M, Risbrough V. M93. No Association Between COMT Val158Met and Prepulse Inhibition: Findings From the Marine Resiliency Study Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx022.088  0.396
2017 Friend S, Deslauriers J, Risbrough V. 291. Relationship between Sub-chronic C-Reactive Protein Exposure and Risk for Post Traumatic Stress Disorder Biological Psychiatry. 81: S119-S120. DOI: 10.1016/J.Biopsych.2017.02.305  0.347
2017 Risbrough V, Geyer M, Acheson D, Minassian A, Maihofer A, Baker D, Nievergelt C. 88. Identification of Psychophysiological Markers of PTSD Risk and Potential Use as Intermediate Phenotypes Biological Psychiatry. 81: S37. DOI: 10.1016/J.Biopsych.2017.02.100  0.452
2016 Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. Prepulse Inhibition Deficits in Obsessive-Compulsive Disorder are More Pronounced in Females. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 41: 2963-2964. PMID 27818517 DOI: 10.1038/Npp.2015.363  0.376
2016 Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. HIGH AND LOW THRESHOLD FOR STARTLE REACTIVITY ASSOCIATED WITH PTSD SYMPTOMS BUT NOT PTSD RISK: EVIDENCE FROM A PROSPECTIVE STUDY OF ACTIVE DUTY MARINES. Depression and Anxiety. PMID 26878585 DOI: 10.1002/Da.22475  0.408
2016 Steinman SA, Ahmari SE, Choo T, Kimeldorf MB, Feit R, Loh S, Risbrough V, Geyer MA, Steinglass JE, Wall M, Schneier FR, Fyer AJ, Simpson HB. PREPULSE INHIBITION DEFICITS ONLY IN FEMALES WITH OBSESSIVE-COMPULSIVE DISORDER. Depression and Anxiety. 33: 238-46. PMID 26878422 DOI: 10.1002/Da.22474  0.487
2015 Toth M, Flandreau EI, Deslauriers J, Geyer MA, Mansuy I, Merlo-Pich E, Risbrough V. Overexpression of Forebrain CRH During Early Life Increases Trauma Susceptibility in Adulthood. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26538448 DOI: 10.1038/Npp.2015.338  0.771
2015 Minassian A, Maihofer AX, Baker DG, Nievergelt CM, Geyer MA, Risbrough VB. Association of Predeployment Heart Rate Variability With Risk of Postdeployment Posttraumatic Stress Disorder in Active-Duty Marines. Jama Psychiatry. 1-8. PMID 26353072 DOI: 10.1001/jamapsychiatry.2015.0922  0.443
2015 Higa KK, Ji B, Buell MR, Risbrough VB, Powell SB, Young JW, Geyer MA, Zhou X. Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26037489 DOI: 10.1093/Ijnp/Pyv063  0.703
2015 Yurgil KA, Clifford RE, Risbrough VB, Geyer MA, Huang M, Barkauskas DA, Vasterling JJ, Baker DG. Prospective Associations Between Traumatic Brain Injury and Postdeployment Tinnitus in Active-Duty Marines. The Journal of Head Trauma Rehabilitation. PMID 25699623 DOI: 10.1097/Htr.0000000000000117  0.375
2015 Flandreau E, Risbrough V, Lu A, Ableitner M, Geyer MA, Holsboer F, Deussing JM. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating. Psychoneuroendocrinology. 53: 16-28. PMID 25575243 DOI: 10.1016/J.Psyneuen.2014.12.005  0.772
2015 Nievergelt CM, Maihofer AX, Mustapic M, Yurgil KA, Schork NJ, Miller MW, Logue MW, Geyer MA, Risbrough VB, O'Connor DT, Baker DG. Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrinology. 51: 459-71. PMID 25456346 DOI: 10.1016/j.psyneuen.2014.10.017  0.426
2015 Acheson DT, Geyer MA, Baker DG, Nievergelt CM, Yurgil K, Risbrough VB. Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines. Psychoneuroendocrinology. 51: 495-505. PMID 25444643 DOI: 10.1016/J.Psyneuen.2014.09.030  0.45
2014 Acheson DT, Geyer MA, Risbrough VB. Psychophysiology in the study of psychological trauma: where are we now and where do we need to be? Current Topics in Behavioral Neurosciences. 21: 157-83. PMID 25158622 DOI: 10.1007/7854_2014_346  0.426
2014 Naviaux JC, Schuchbauer MA, Li K, Wang L, Risbrough VB, Powell SB, Naviaux RK. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Translational Psychiatry. 4: e400. PMID 24937094 DOI: 10.1038/Tp.2014.33  0.588
2014 Minassian A, Geyer MA, Baker DG, Nievergelt CM, O'Connor DT, Risbrough VB. Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress. Psychosomatic Medicine. 76: 292-301. PMID 24804881 DOI: 10.1097/PSY.0000000000000056  0.436
2014 Risbrough V, Ji B, Hauger R, Zhou X. Generation and characterization of humanized mice carrying COMT158 Met/Val alleles. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1823-32. PMID 24509724 DOI: 10.1038/Npp.2014.29  0.37
2014 van Enkhuizen J, Acheson D, Risbrough V, Drummond S, Geyer MA, Young JW. Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice. Behavioural Brain Research. 261: 40-8. PMID 24333377 DOI: 10.1016/J.Bbr.2013.12.003  0.535
2014 Toth M, Gresack JE, Bangasser DA, Plona Z, Valentino RJ, Flandreau EI, Mansuy IM, Merlo-Pich E, Geyer MA, Risbrough VB. Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1409-19. PMID 24326400 DOI: 10.1038/Npp.2013.336  0.784
2013 Toth M, Gresack JE, Hauger RL, Halberstadt AL, Risbrough VB. The role of PKC signaling in CRF-induced modulation of startle. Psychopharmacology. 229: 579-89. PMID 23722830 DOI: 10.1007/S00213-013-3114-9  0.619
2013 Tatro ET, Risbrough V, Soontornniyomkij B, Young J, Shumaker-Armstrong S, Jeste DV, Achim CL. Short-term recognition memory correlates with regional CNS expression of microRNA-138 in mice. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 21: 461-73. PMID 23570889 DOI: 10.1016/J.Jagp.2012.09.005  0.469
2013 Liu X, Hong SI, Park SJ, Dela Peña JB, Che H, Yoon SY, Kim DH, Kim JM, Cai M, Risbrough V, Geyer MA, Shin CY, Cheong JH, Park H, Lew JH, et al. The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice. Archives of Pharmacal Research. 36: 854-63. PMID 23543630 DOI: 10.1007/S12272-013-0106-6  0.489
2013 Toth M, Ziegler M, Sun P, Gresack J, Risbrough V. Impaired conditioned fear response and startle reactivity in epinephrine-deficient mice. Behavioural Pharmacology. 24: 1-9. PMID 23268986 DOI: 10.1097/Fbp.0B013E32835Cf408  0.39
2012 Bomyea J, Risbrough V, Lang AJ. A consideration of select pre-trauma factors as key vulnerabilities in PTSD. Clinical Psychology Review. 32: 630-41. PMID 22917742 DOI: 10.1016/J.Cpr.2012.06.008  0.371
2012 Baker DG, Nash WP, Litz BT, Geyer MA, Risbrough VB, Nievergelt CM, O'Connor DT, Larson GE, Schork NJ, Vasterling JJ, Hammer PS, Webb-Murphy JA. Predictors of risk and resilience for posttraumatic stress disorder among ground combat Marines: methods of the Marine Resiliency Study. Preventing Chronic Disease. 9: E97. PMID 22575082 DOI: 10.5888/pcd9.110134  0.405
2012 Acheson DT, Stein MB, Paulus MP, Geyer MA, Risbrough VB. The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. Neuropharmacology. 63: 480-5. PMID 22575075 DOI: 10.1016/J.Neuropharm.2012.04.018  0.393
2012 Soontornniyomkij V, Risbrough VB, Young JW, Soontornniyomkij B, Jeste DV, Achim CL. Hippocampal calbindin-1 immunoreactivity correlate of recognition memory performance in aged mice. Neuroscience Letters. 516: 161-5. PMID 22503902 DOI: 10.1016/J.Neulet.2012.03.092  0.443
2012 Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1216-23. PMID 22218093 DOI: 10.1038/Npp.2011.308  0.385
2012 Steckler T, Risbrough V. Pharmacological treatment of PTSD - established and new approaches. Neuropharmacology. 62: 617-27. PMID 21736888 DOI: 10.1016/J.Neuropharm.2011.06.012  0.379
2012 Soontornniyomkij V, Risbrough VB, Young JW, Soontornniyomkij B, Jeste DV, Achim CL. Increased hippocampal accumulation of autophagosomes predicts short-term recognition memory impairment in aged mice. Age (Dordrecht, Netherlands). 34: 305-16. PMID 21431350 DOI: 10.1007/S11357-011-9234-4  0.448
2012 Risbrough V, Baker DG, Nievergelt C, Litz B, Nash W, Perez J, Geyer M. Prospective assessment of psychophysiological risk factors for PTSD European Journal of Psychotraumatology. 3. DOI: 10.3402/Ejpt.V3I0.19473  0.451
2011 Tanaka S, Young JW, Gresack JE, Geyer MA, Risbrough VB. Factor analysis of attentional set-shifting performance in young and aged mice. Behavioral and Brain Functions : Bbf. 7: 33. PMID 21838910 DOI: 10.1186/1744-9081-7-33  0.548
2011 van den Buuse M, Ruimschotel E, Martin S, Risbrough VB, Halberstadt AL. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia. Neuropharmacology. 61: 209-16. PMID 21501627 DOI: 10.1016/J.Neuropharm.2011.04.001  0.596
2011 van den Buuse M, Becker T, Kwek P, Martin S, Ruimschotel E, Risbrough V. Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT(1A) receptor knockout mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 856-61. PMID 21329554 DOI: 10.1017/S1461145711000101  0.329
2011 Ali SS, Young JW, Wallace CK, Gresack J, Jeste DV, Geyer MA, Dugan LL, Risbrough VB. Initial evidence linking synaptic superoxide production with poor short-term memory in aged mice. Brain Research. 1368: 65-70. PMID 21075081 DOI: 10.1016/J.Brainres.2010.11.009  0.54
2010 Risbrough V. Behavioral correlates of anxiety. Current Topics in Behavioral Neurosciences. 2: 205-28. PMID 21309111 DOI: 10.1007/7854_2009_11  0.338
2010 Young JW, Powell SB, Geyer MA, Jeste DV, Risbrough VB. The mouse attentional-set-shifting task: a method for assaying successful cognitive aging? Cognitive, Affective & Behavioral Neuroscience. 10: 243-51. PMID 20498348 DOI: 10.3758/Cabn.10.2.243  0.696
2010 Gresack J, Powell S, Geyer M, Poore MS, Coste S, Risbrough V. CRF2 null mutation increases sensitivity to isolation rearing effects on locomotor activity in mice. Neuropeptides. 44: 349-53. PMID 20466421 DOI: 10.1016/J.Npep.2010.04.005  0.711
2010 Soontornniyomkij V, Risbrough VB, Young JW, Wallace CK, Soontornniyomkij B, Jeste DV, Achim CL. Short-term recognition memory impairment is associated with decreased expression of FK506 binding protein 51 in the aged mouse brain. Age (Dordrecht, Netherlands). 32: 309-22. PMID 20422297 DOI: 10.1007/S11357-010-9145-9  0.464
2010 Young JW, Wallace CK, Geyer MA, Risbrough VB. Age-associated improvements in cross-modal prepulse inhibition in mice. Behavioral Neuroscience. 124: 133-40. PMID 20141288 DOI: 10.1037/A0018462  0.546
2010 Gresack JE, Risbrough VB, Scott CN, Coste S, Stenzel-Poore M, Geyer MA, Powell SB. Isolation rearing-induced deficits in contextual fear learning do not require CRF(2) receptors. Behavioural Brain Research. 209: 80-4. PMID 20097235 DOI: 10.1016/J.Bbr.2010.01.018  0.695
2010 Adamec R, Fougere D, Risbrough V. CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 747-57. PMID 19751543 DOI: 10.1017/S1461145709990496  0.449
2009 Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Annals of the New York Academy of Sciences. 1179: 120-43. PMID 19906236 DOI: 10.1111/J.1749-6632.2009.05011.X  0.338
2009 Duvvuri V, Risbrough VB, Kaye WH, Geyer MA. 5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition. Pharmacology, Biochemistry, and Behavior. 93: 349-53. PMID 19490926 DOI: 10.1016/J.Pbb.2009.05.014  0.416
2009 Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1958-67. PMID 19322172 DOI: 10.1038/Npp.2009.29  0.718
2009 Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacology & Therapeutics. 122: 150-202. PMID 19269307 DOI: 10.1016/J.Pharmthera.2009.02.004  0.69
2009 Risbrough VB, Geyer MA, Hauger RL, Coste S, Stenzel-Poore M, Wurst W, Holsboer F. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 1494-503. PMID 19020499 DOI: 10.1038/Npp.2008.205  0.505
2009 Tanaka S, Risbrough V, Young J, Gresack J, Geyer M. N-factor models of cognitive and behavioral functions of aged and young mice Neuroscience Research. 65: S117. DOI: 10.1016/J.Neures.2009.09.546  0.591
2008 Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology. 201: 55-66. PMID 18604652 DOI: 10.1007/S00213-008-1247-Z  0.643
2008 Jonkman S, Risbrough VB, Geyer MA, Markou A. Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2131-8. PMID 18033237 DOI: 10.1038/Sj.Npp.1301607  0.384
2008 Risbrough VB, Geyer MA. Preclinical Approaches to Understanding Anxiety Disorders Oxford Handbook of Anxiety and Related Disorders. DOI: 10.1093/oxfordhb/9780195307030.013.0007  0.373
2007 Vinkers CH, Risbrough VB, Geyer MA, Caldwell S, Low MJ, Hauger RL. Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. Pharmacology, Biochemistry, and Behavior. 86: 550-8. PMID 17324452 DOI: 10.1016/J.Pbb.2007.01.018  0.417
2006 Hauger RL, Risbrough V, Brauns O, Dautzenberg FM. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. Cns & Neurological Disorders Drug Targets. 5: 453-79. PMID 16918397 DOI: 10.2174/187152706777950684  0.378
2006 Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 2349-58. PMID 16855533 DOI: 10.1038/Sj.Npp.1301161  0.389
2005 Risbrough VB, Geyer MA. Anxiogenic treatments do not increase fear-potentiated startle in mice. Biological Psychiatry. 57: 33-43. PMID 15607298 DOI: 10.1016/j.biopsych.2004.10.006  0.42
2004 Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6545-52. PMID 15269266 DOI: 10.1523/JNEUROSCI.5760-03.2004  0.593
2003 Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology. 170: 178-87. PMID 12845406 DOI: 10.1007/s00213-003-1535-6  0.444
2003 Risbrough VB, Brodkin JD, Geyer MA. GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 654-63. PMID 12655310 DOI: 10.1038/sj.npp.1300079  0.415
2003 Powell SB, Risbrough VB, Geyer MA. Potential use of animal models to examine antipsychotic prophylaxis for schizophrenia Clinical Neuroscience Research. 3: 289-296. DOI: 10.1016/S1566-2772(03)00089-6  0.632
Show low-probability matches.